Financials data is unavailable for this security.
View more
Year on year ANI Pharmaceuticals Inc grew revenues 53.87% from 316.39m to 486.82m while net income improved from a loss of 47.90m to a gain of 18.78m.
Gross margin | 61.34% |
---|---|
Net profit margin | 5.01% |
Operating margin | 9.31% |
Return on assets | 3.04% |
---|---|
Return on equity | 5.30% |
Return on investment | 3.56% |
More ▼
Cash flow in USDView more
In 2023, ANI Pharmaceuticals Inc increased its cash reserves by 315.38%, or 167.89m. The company earned 118.96m from its operations for a Cash Flow Margin of 24.44%. In addition the company generated 67.44m cash from financing while 18.51m was spent on investing.
Cash flow per share | 4.41 |
---|---|
Price/Cash flow per share | 15.17 |
Book value per share | 22.81 |
---|---|
Tangible book value per share | 12.78 |
More ▼
Balance sheet in USDView more
Current ratio | 3.97 |
---|---|
Quick ratio | 3.07 |
Total debt/total equity | 0.5935 |
---|---|
Total debt/total capital | 0.3725 |
More ▼
Growth rates in USD
SmartText is unavailable
EPS growth(5 years) | -8.16 |
---|---|
EPS (TTM) vs TTM 1 year ago | 335.46 |